Public company info - SciClone Pharmaceuticals (Holdings) Limited , 06600.HK

Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

SciClone Pharmaceuticals (Holdings) Limited, 06600.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12
Net Cash Flow from Operating Activities 1,268,804 1,213,580 1,031,590 1,046,547 349,181 166,684
Net Cash Flow from Return on Investments & Servicing of Finance -223,646 -867,206 -2,187,103 -200,821 -558,936 5,778
 Interest Received 28,762 7,958 8,577 11,964 6,225 7,522
 Interest Paid -46,786 -47,861 -21,922 -212,785 -565,161 -1,744
 Dividend Received 0 0 0 0 0 0
 Dividend Paid -205,622 -827,303 -2,173,758 0 0 0
 Others 0 0 0 0 0 0
Taxes (Paid) / Refunded -67,212 -144,221 -37,278 -25,696 -182,657 -12,611
Net Cash Flow from Investing Activities -1,025,549 -126,237 -670,629 -152,490 171,145 -10,728
 Additions to Fixed Assets -5,768 -5,700 -3,747 -1,947 -12,447 -6,293
 Disposal of Fixed Assets 448 272 0 0 0 0
 Increase in Investments -673,588 -1,134,412 -1,060,980 -626,976 -13,726 0
 Decrease in Investments 531,712 1,109,326 1,022,840 507,128 127,455 0
 Net Cash Flow with Related Parties 0 0 0 0 45,347 0
 Others -878,353 -95,723 -628,742 -30,695 24,516 -4,435
Net Cash Flow before Financing Activities -47,603 75,916 -1,863,420 667,540 -221,267 149,123
Net Cash Flow from Financing Activities -464,640 942,872 2,120,418 -22,993 20,790 -476,526
 New Loans 0 0 2,123,850 0 0 0
 Loans Repayment -447,812 -788,123 -19,283 -22,993 -24,557 -23,948
 Fixed Income/Debt Instruments 0 0 0 0 0 0
 Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0
 Equity Financing 16,005 1,734,174 21,452 0 0 19,169
 Net Cash Flow with Related Parties 0 0 0 0 45,347 0
 Others -32,833 -3,179 -5,601 0 0 -471,747
Increase(Decrease) in Cash & Cash Equivalents -512,243 1,018,788 256,998 644,547 -200,477 -327,403
Cash & Cash Equivalents at Beginning of Year 2,127,488 1,118,986 919,490 275,962 481,629 795,633
Net Cash Flow due to Change in Exchange Rate/Others 56,584 -10,286 -57,502 -1,019 -5,190 13,399
Cash & Cash Equivalents at End of Year 1,671,829 2,127,488 1,118,986 919,490 275,962 481,629
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 0 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2024
Suntek Computer Systems Limited.
All rights reserved